SLC5A2 and liver dysplastic nodule: Interestingly, the sodium-glucose cotransporter 2 inhibitors, a new class of hypoglycemic drugs, have previously been found to ameliorate kidney structure and decelerate DN progression, possibly through their protective effect on injury of the proximal renal tubular cells [24].